
    
      Osteoporosis, diabetes, metabolic syndrome and cardiovascular disease are common diseases
      that affect large groups of people in the Western world.

      Our hypotheses is that vitamin K2 (MK-7) reduces undercarboxylated osteocalcin in
      postmenopausal women and reduces bone turnover and increases bone mineral density; increases
      insulin sensitivity and decreases indices of arterial calcification.
    
  